Macroangiopathy and Associated Factors in Outpatients with Type 2 Diabetes Attending the Antidiabetic Center of Abidjan in Ivory Coast
Science Journal of Public Health
Volume 5, Issue 4, July 2017, Pages: 347-352
Received: May 16, 2017; Accepted: Jun. 1, 2017; Published: Jul. 21, 2017
Views 1541      Downloads 40
Authors
Aké-Tano Sassor Odile Purifine, National Institute of Public Health, Abidjan, Ivory Coast; Public Health and Biostatistics Department, Training and Research Unit of Medical School, University Félix Houphouet Boigny, Abidjan, Ivory Coast
Ekou Franck Kokora, National Institute of Public Health, Abidjan, Ivory Coast; Public Health and Biostatistics Department, Training and Research Unit of Medical School, University Félix Houphouet Boigny, Abidjan, Ivory Coast
Kpebo Djoukou Olga Denise, National Institute of Public Health, Abidjan, Ivory Coast; Public Health and Biostatistics Department, Training and Research Unit of Medical School, University Félix Houphouet Boigny, Abidjan, Ivory Coast
Aka Felix, National Institute of Public Health, Abidjan, Ivory Coast
Konan Yao Eugène, National Institute of Public Health, Abidjan, Ivory Coast; Public Health and Biostatistics Department, Training and Research Unit of Medical School, University Félix Houphouet Boigny, Abidjan, Ivory Coast
Tetchi Ekissi Orsot, National Institute of Public Health, Abidjan, Ivory Coast; Public Health and Biostatistics Department, Training and Research Unit of Medical School, University Félix Houphouet Boigny, Abidjan, Ivory Coast
Sablé Parfait Sable, National Institute of Public Health, Abidjan, Ivory Coast; Public Health and Biostatistics Department, Training and Research Unit of Medical School, University Félix Houphouet Boigny, Abidjan, Ivory Coast
Malan Léa, National Institute of Public Health, Abidjan, Ivory Coast
Kouassi Dinard, National Institute of Public Health, Abidjan, Ivory Coast
Article Tools
Follow on us
Abstract
Diabetes constitutes a major public health concern, especially in developing countries, due to its frequency and severity related to the macroangiopathy complications. This study aimed at estimating the prevalence of macroangiopathy in type 2 diabetic outpatients attending the Antidiabetic Center of Abidjan (ADCA) and identifying the associated factors. It was a retrospective and analytic study that was conducted in 2014 at the ADCA. In total, 377 diabetic outpatients were included in the study. Patients had a mean age of 61.3 (SD: 8.9) years and were suffering diabetes for a mean duration of 11.8 years (SD: 5.6). In 95.5% of the cases, at least one cardiovascular disease risk factor was associated to diabetes. It was high level of cholesterol (37.1%), high level of Low Density Lipoprotein (LDL) cholesterol (72.4%), low level of High Density Lipoprotein (HDL) cholesterol (20.9%), high level of triglycerides (10.3%), hypertension (67.4%), and obesity (18.8%). Macroangiopathy was diagnosed in 62 out of 377 patients, meaning 16.4%. It was a coronary disease (44/377 meaning 11.7%), vascular cerebral accident (11/377 meaning 2.9%) and peripheral arterial disease of the lower limbs (10/377 meaning 2.7%). Diabetic patients with hypertension were more likely to have a macroangiopathy as compared to those without hypertension (p = 0.024; OR2.57, IC = [1. 13-5.85]). In addition, patients presenting a low level of HDL cholesterol were likely to have a coronary heart disease as compared to those with a normal level of HDL cholesterol (p = 0.008); OR = 2.72, IC [1.28-5.76]. With regard to the severity of macroangiopathy complications, it is tremendous to reinforce the medical management of cardiovascular disease risk factors in type 2 diabetes patients in Ivory Coast.
Keywords
Type 2 Diabetes, Macroangiopathy, Associated Factors, Ivory Coast
To cite this article
Aké-Tano Sassor Odile Purifine, Ekou Franck Kokora, Kpebo Djoukou Olga Denise, Aka Felix, Konan Yao Eugène, Tetchi Ekissi Orsot, Sablé Parfait Sable, Malan Léa, Kouassi Dinard, Macroangiopathy and Associated Factors in Outpatients with Type 2 Diabetes Attending the Antidiabetic Center of Abidjan in Ivory Coast, Science Journal of Public Health. Vol. 5, No. 4, 2017, pp. 347-352. doi: 10.11648/j.sjph.20170504.21
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Fédération Internationale du Diabète. Atlas du diabète de la FID. 6è éd; 2013. Available on: http://www.idf.org/diabetesatlas
[2]
Grimaldi A. Traité de diabétologie. 2è Ed. Paris: Médecine-Sciences Flammarion, 2009: 1044p.
[3]
Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001; 37 (4): 1053–9.
[4]
Legret D. Le diabète du sujet âgé en Côte d’Ivoire [thèse Med]. Abidjan: U. F. R des Sciences Médicales; 2002, n°3105. 209p.
[5]
Allechi C. Formes clinques du diabète sucré à Abidjan: Etude typologique de 1000 cas [thèse Med]. Abidjan, 1993, n°1484. 256p.
[6]
Deconinck B, Mathieu C, Benhalima K. Characteristics and cardiovascular complications of a large cohort of adults diagnosed with type 2 diabetes < 45 years. Diabetol Metab Syndr 2017; 9: 28. doi 10.1186/s13098-017-0227-z.
[7]
Sibailly P. Contribution à l’étude des complications du diabète sucré en Côte d’Ivoire. Etude transversale chez 300 patients [thèse Med]. Abidjan, 1998, n°2172. 350 p.
[8]
Abodo J. Aspects du diabète sucré chez le noir africain à l’Hôpital Militaire d’Abidjan à propos de 473 cas colligés du 1er janvier 1995 au 31 décembre 1999 [thèse Med]. Abidjan, 2000, n°2635. 212 p.
[9]
Aphala O. Bilan de 40 années d’activités de prise en charge du diabète en Côte d’Ivoire: caractéristiques épidémiologiques et cliniques des patients suivis au Centre Antidiabétique d’Abidjan (CADA). Diabetes & Metabolism 2016; 42, Supplement 1: A24-A25.
[10]
Ouédraogo S. Etude des atteintes cardio-vasculaires au cours du diabète de sucré au Centre Hospitalier National Sanon Souro de Bobo-Dioulasso [thèse Med]. Ouagadougou, 1997, n°15. 229 p.
[11]
Filali BK, Ouhadouche F, Diouri A. La macro-angiopathie chez le diabétique: Profil clinique et épidémiologique. À propos de 122 cas. Diabetes & Metabolism 2009; 35, Supplement 1: A78.
[12]
Druet C. Echantillon national témoin représentatif des personnes diabétiques. Entred 2007-2010. Saint-Maurice: Institut de veille sanitaire; 2012. 8p.
[13]
Stamler J, Vaccaro O, Neaton J, Wentworth D. Diabetes, other risk factors and 12 years cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Cares 1993; 16: 434-44.
[14]
Bertoluci CM, Rocha ZV. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr 2017; 9: 25. doi 10.1186/s13098-017-0225-1.
[15]
Konin C, N’Loo EAS, Adoubi A, Coulibaly I, N’Guetta R, Boka B et all. Artériopathie des Membres Inférieurs du diabétique noir africain: aspects ultrasoniques et facteurs déterminants. Journal des Maladies Vasculaires 2014; 39: 373-81.
[16]
Turner RC, Millins H, Stratton IM et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: UKPDS 23. BMJ 1998; 316: 823-82.
[17]
Organisation Mondiale de la Santé. Rapport sur la santé dans le monde 2002: réduire les risques et promouvoir une vie saine. Chapitre 4 – Quantification de certains risques majeurs pour la santé. OMS 2002, p 51-104.
[18]
Summary of the second National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993; 269: 3015-23.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186